Terms: = Leukemia AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
68856 results:
1. Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid leukemia.
Basingab FS; Alzahrani RA; Alrofaidi AA; Barefah AS; Hammad RM; Alahdal HM; Alrahimi JS; Zaher KA; Algiraigri AH; El-Daly MM; Alkarim SA; Aldahlawi AM
Biomolecules; 2024 Apr; 14(5):. PubMed ID: 38785930
[TBL] [Abstract] [Full Text] [Related]
2. Combining inotuzumab ozogamicin with PARP inhibitors olaparib and talazoparib exerts synergistic cytotoxicity in acute lymphoblastic leukemia by inhibiting DNA strand break repair.
Ida N; Okura M; Tanaka S; Hosono N; Yamauchi T
Oncol Rep; 2024 Jul; 52(1):. PubMed ID: 38785163
[TBL] [Abstract] [Full Text] [Related]
3. Combination Effect of Deferoxamine and Arsenic Trioxide on Viability and Vitality of APL Like Cell Line.
Ghaffari K; Bayat A; Ghasemi A
Ethiop J Health Sci; 2023 Jul; 33(4):703-710. PubMed ID: 38784214
[TBL] [Abstract] [Full Text] [Related]
4. Illness cognition and associated socio-demographic and clinical factors in parents of children with leukemia.
Han J; Zhang L; Yang F; Wang L
BMC Psychol; 2024 May; 12(1):289. PubMed ID: 38783376
[TBL] [Abstract] [Full Text] [Related]
5. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
[TBL] [Abstract] [Full Text] [Related]
6. Evaluation of the prevalence of Aeromonas spp., Campylobacter spp., and Clostridioides difficile in immunocompromised children with diarrhea.
Heydari H; Iranikhah A; Ghasemi A; Mohammadbeigi A; Sadat-Mirei SA; Shams S; Kermani S
BMC Infect Dis; 2024 May; 24(1):512. PubMed ID: 38778271
[TBL] [Abstract] [Full Text] [Related]
7. Low subcutaneous adipose tissue and myosteatosis are prognostic factors after allogeneic hematopoietic stem cell transplantation.
Barajas Ordonez F; Zeller Y; Wolleschak D; Hinnerichs M; Rodríguez-Feria P; Mougiakakos D; Aghayev A; Kardas H; Mikusko M; Borggrefe J; Surov A
Clin Nutr ESPEN; 2024 Jun; 61():274-280. PubMed ID: 38777443
[TBL] [Abstract] [Full Text] [Related]
8. flt3-ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia.
Turos-Cabal M; Sánchez-Sánchez AM; Puente-Moncada N; Herrera F; Antolin I; Rodríguez C; Martín V
Hematol Oncol; 2024 May; 42(3):e3281. PubMed ID: 38775115
[TBL] [Abstract] [Full Text] [Related]
9. Treatment intensity affects immune reconstitution even after childhood cancer not treated with hematopoietic stem cell transplantation.
Antikainen E; Grönroos M; Huurre A; Korhonen L; Peltola V; Lähteenmäki P; Schuez-Havupalo L
Cancer Rep (Hoboken); 2024 May; 7(5):e2069. PubMed ID: 38767518
[TBL] [Abstract] [Full Text] [Related]
10. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
[TBL] [Abstract] [Full Text] [Related]
11. Breaking barriers: supporting hematopoietic stem cell transplant program through collaborative radiation therapy service from a physically distant center.
Pandit S; Sapkota S; Adhikari A; Karki P; Shrestha R; Jha DS; Prajapati R; Nyaichyai KS; Poudyal BS; Poudel B; Jha AK
J Egypt Natl Canc Inst; 2024 May; 36(1):17. PubMed ID: 38764073
[TBL] [Abstract] [Full Text] [Related]
12. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
[TBL] [Abstract] [Full Text] [Related]
13. Cd(II)-based complex loaded with drug doxorubicin hydrogels against leukemia and reinforcement learning.
Chen M; Chen D; Li G; Wu Y
Sci Rep; 2024 May; 14(1):11350. PubMed ID: 38762628
[TBL] [Abstract] [Full Text] [Related]
14. Cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
15. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
16. Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid leukemia.
Lamba JK; Marrero R; Wu H; Cao X; Parcha PK; Karol SE; Inaba H; Kuo DJ; Degar BA; Heym K; Taub JW; Lacayo NJ; Pui CH; Ribeiro RC; Pounds SB; Rubnitz JE
JAMA Netw Open; 2024 May; 7(5):e2411726. PubMed ID: 38753328
[TBL] [Abstract] [Full Text] [Related]
17. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in Cancer: A Systematic Review and Meta-Analysis.
Gao L; Fan J; He J; Che X; Wang X; Han C
Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
[TBL] [Abstract] [Full Text] [Related]
18. The efficacy of the combination of venetoclax and hypomethylating agents versus HAG agents in patients with acute myeloid leukemia: a retrospective study.
Xin F; Yu YH; Shen XL; Zhang GX
Hematology; 2024 Dec; 29(1):2350319. PubMed ID: 38748459
[TBL] [Abstract] [Full Text] [Related]
19. Drug Analysis of Voriconazole Combined with Granulocyte Colony Stimulating Factor.
Zhang X; Li R; Wang H; Li H; Wu Y
Clin Lab; 2024 May; 70(5):. PubMed ID: 38747920
[TBL] [Abstract] [Full Text] [Related]
20. Real-world data on diagnostics, treatment and outcomes of patients with hairy cell leukemia: The HCL-CLLEAR study.
Panovská A; Žák P; Jurková T; Arpáš T; Brychtová Y; Vašíková A; Hrabčáková V; Prchlíková A; Filipová M; Doubek M
Hematol Oncol; 2024 May; 42(3):e3280. PubMed ID: 38741354
[TBL] [Abstract] [Full Text] [Related]
[Next]
